{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:21:37Z","timestamp":1756462897129},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1007\/s11938-000-0025-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:07:05Z","timestamp":1180890425000},"page":"217-226","source":"Crossref","is-referenced-by-count":3,"title":["Fulminant ulcerative colitis"],"prefix":"10.1007","volume":"3","author":[{"given":"Clarence K. W.","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. R.","family":"Yacyshyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"25_CR1","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ: Cortisone in ulcerative colitis: final report on a therapeutic trial. BMJ 1955, 2:1041\u20131048.","journal-title":"BMJ"},{"key":"25_CR2","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/BF02237298","volume":"41","author":"NC Swan","year":"1998","unstructured":"Swan NC, Geoghegan JG, O\u2019Donoghue DP, et al.: Fulminant colitis in inflammatory bowel disease: detailed pathologic and clinical analysis. Dis Colon Rectum 1998, 41:1511\u20131515. A good corellation of clinical and pathological findings in fulminant UC.","journal-title":"Dis Colon Rectum"},{"key":"25_CR3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1056\/NEJM198703193161202","volume":"316","author":"EJ Boyko","year":"1987","unstructured":"Boyko EJ, Koepsell TD, Perera DR, Inui TS: Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987, 316:707\u2013710.","journal-title":"N Engl J Med"},{"key":"25_CR4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/0016-5085(80)90913-0","volume":"79","author":"RJ Dickinson","year":"1980","unstructured":"Dickinson RJ, Ashton MG, Axon AT, et al.: Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology 1980, 79:1199\u20131204.","journal-title":"Gastroenterology"},{"key":"25_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/gut.27.5.481","volume":"27","author":"PB McIntyre","year":"1986","unstructured":"McIntyre PB, Powell-Tuck J, Wood SR, et al.: Controlled trial of bowel rest in the treatment of severe acute colitis. Gut 1986, 27:481\u2013485.","journal-title":"Gut"},{"key":"25_CR6","first-page":"204","volume":"92","author":"A Kornbluth","year":"1997","unstructured":"Kornbluth A, Sachar DB: Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 1997, 92:204\u2013211. A current guideline to practice.","journal-title":"Am J Gastroenterol"},{"key":"25_CR7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00004836-199002000-00011","volume":"12","author":"W Rosenberg","year":"1990","unstructured":"Rosenberg W, Ireland A, Jewell DP: High-dose methylprednisolone in the treatment of active ulcerative colitis. J Clin Gastroenterol 1990, 12:40\u201341.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00004836-198702000-00013","volume":"9","author":"S Meyers","year":"1987","unstructured":"Meyers S, Lerer PK, Feuer EJ, et al.: Predicting the outcome of corticoid therapy for acute ulcerative colitis. Results of a prospective, randomized, doubleblind clinical trial. J Clin Gastroenterol 1987, 9:50\u201354.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR9","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0016-5085(83)90323-2","volume":"85","author":"S Meyers","year":"1983","unstructured":"Meyers S, Sachar DB, Goldberg JD, Janowitz HD: Corticotropin versus hydrocortisone in the intravenous treatment of ulcerative colitis. A prospective, randomized, double-blind clinical trial. Gastroenterology 1983, 85:351\u2013357.","journal-title":"Gastroenterology"},{"key":"25_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0016-5085(19)32640-X","volume":"69","author":"HP Kaplan","year":"1975","unstructured":"Kaplan HP, Portnoy B, Binder HJ, et al.: A controlled evaluation of intravenous adrenocorticotropic hormone and hydrocortisone in the treatment of acute colitis. Gastroenterology 1975, 69:91\u201395.","journal-title":"Gastroenterology"},{"key":"25_CR11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004836-199506000-00004","volume":"20","author":"A Kornbluth","year":"1995","unstructured":"Kornbluth A, Marion JF, Salomon P, Janowitz HD: How effective is current medical therapy for severe ulcerative and Crohn\u2019s colitis? An analytic review of selected trials. J Clin Gastroenterol 1995, 20:280\u2013284.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR12","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/0016-5085(85)90201-X","volume":"89","author":"G Jarnerot","year":"1985","unstructured":"Jarnerot G, Rolny P, Sandberg-Gertzen H: Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985, 89:1005\u20131013.","journal-title":"Gastroenterology"},{"key":"25_CR13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/gut.38.6.905","volume":"38","author":"SP Travis","year":"1996","unstructured":"Travis SP, Farrant JM, Ricketts C, et al.: Predicting outcome in severe ulcerative colitis. Gut 1996, 38:905\u2013910.","journal-title":"Gut"},{"key":"25_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0889-8553(21)00425-8","volume":"18","author":"G Gitnick","year":"1989","unstructured":"Gitnick G: Antibiotics and inflammatory bowel diseases. Gastroenterol Clin North Am 1989, 18:51\u201356.","journal-title":"Gastroenterol Clin North Am"},{"key":"25_CR15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02235178","volume":"42","author":"HS Kaufman","year":"1999","unstructured":"Kaufman HS, Kahn AC, Iacobuzio-Donahue C, et al.: Cytomegaloviral enterocolitis: clinical associations and outcome. Dis Colon Rectum 1999, 42:24\u201330. A disease to think about in the differential diagnosis of fulminant UC.","journal-title":"Dis Colon Rectum"},{"key":"25_CR16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00004836-199412000-00010","volume":"19","author":"EV Loftus Jr","year":"1994","unstructured":"Loftus EV Jr, Alexander GL, Carpenter HA: Cytomegalovirus as an exacerbating factor in ulcerative colitis. J Clin Gastroenterol 1994, 19:306\u2013309.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1080\/00365529850171765","volume":"33","author":"M Chiba","year":"1998","unstructured":"Chiba M, Fukushima T, Koganei K, et al.: Listeria monocytogenes in the colon in a case of fulminant ulcerative colitis. Scand J Gastroenterol 1998, 33:778\u2013782.","journal-title":"Scand J Gastroenterol"},{"key":"25_CR18","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/00004836-198908000-00008","volume":"11","author":"T Gilat","year":"1989","unstructured":"Gilat T, Leichtman G, Delpre G, et al.: A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis. J Clin Gastroenterol 1989, 11:392\u2013395.","journal-title":"J Clin Gastroenterol"},{"key":"25_CR19","first-page":"43","volume":"89","author":"GJ Mantzaris","year":"1994","unstructured":"Mantzaris GJ, Hatzis A, Kontogiannis P, Triadaphyllou G: Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1994, 89:43\u201346.","journal-title":"Am J Gastroenterol"},{"key":"25_CR20","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.27.10.1210","volume":"27","author":"RW Chapman","year":"1986","unstructured":"Chapman RW, Selby WS, Jewell DP: Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986, 27:1210\u20131212.","journal-title":"Gut"},{"key":"25_CR21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/00042737-199709000-00002","volume":"9","author":"JF Marion","year":"1997","unstructured":"Marion JF, Present DH: The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 1997, 9:831\u2013835.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"25_CR22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJM199603283341307","volume":"334","author":"SB Hanauer","year":"1996","unstructured":"Hanauer SB: Review articles: Drug therapy: Inflammatory Bowel Disease. N Engl J Med 1996, 334:841\u2013848. A good review.","journal-title":"N Engl J Med"},{"key":"25_CR23","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/0016-5085(94)90832-X","volume":"107","author":"WJ Sandborn","year":"1994","unstructured":"Sandborn WJ: Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment [comments]. Gastroenterology 1994, 107:1856\u20131860.","journal-title":"Gastroenterology"},{"key":"25_CR24","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archsurg.1996.01430170043007","volume":"131","author":"RD Hurst","year":"1996","unstructured":"Hurst RD, Molinari M, Chung TP, et al.: Prospective study of the incidence, timing and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996, 131:497\u2013502.","journal-title":"Arch Surg"},{"key":"25_CR25","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/BF02093783","volume":"39","author":"MV Madden","year":"1994","unstructured":"Madden MV, McIntyre AS, Nicholls RJ: Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994, 39:1193\u20131196.","journal-title":"Dig Dis Sci"},{"key":"25_CR26","first-page":"454","volume":"92","author":"GJ Mantzaris","year":"1997","unstructured":"Mantzaris GJ, Archavlis E, Christoforidis P, et al.: A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997, 92:454\u2013456.","journal-title":"Am J Gastroenterol"},{"key":"25_CR27","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0016-5085(98)70076-9","volume":"115","author":"UM Turunen","year":"1998","unstructured":"Turunen UM, Farkkila MA, Hakala K, et al.: Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study [comments]. Gastroenterology 1998, 115:1072\u20131078.","journal-title":"Gastroenterology"},{"key":"25_CR28","first-page":"620","volume":"99","author":"DK Lee","year":"1986","unstructured":"Lee DK, Cooper BT, Barbezat GO: Clostridium difficile toxin in chronic idiopathic colitis. N Z Med J 1986, 99:620\u2013622.","journal-title":"N Z Med J"},{"key":"25_CR29","first-page":"85","volume":"29","author":"YM Trnka","year":"1984","unstructured":"Trnka YM, Lamont JT: Clostridium difficile colitis. Adv Intern Med 1984, 29:85\u2013107.","journal-title":"Adv Intern Med"},{"key":"25_CR30","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/gut.26.12.1380","volume":"26","author":"RJ Dickinson","year":"1985","unstructured":"Dickinson RJ, O\u2019Connor HJ, Pinder I, et al.: Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis. Gut 1985, 26:1380\u20131384.","journal-title":"Gut"},{"key":"25_CR31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.1990.tb00456.x","volume":"4","author":"DA Burke","year":"1990","unstructured":"Burke DA, Axon AT, Clayden SA, et al.: The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther 1990, 4:123\u2013129.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR32","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.1993.tb00084.x","volume":"7","author":"AJ Lobo","year":"1993","unstructured":"Lobo AJ, Burke DA, Sobala GM, Axon AT: Oral tobramycin in ulcerative colitis: effect on maintenance of remission. Aliment Pharmacol Ther 1993, 7:155\u2013158.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0140-6736(90)91521-B","volume":"336","author":"S Lichtiger","year":"1990","unstructured":"Lichtiger S, Present DH: Preliminary report: cyclosporin in treatment of severe active ulcerative colitis [comments]. Lancet 1990, 336:16\u201319.","journal-title":"Lancet"},{"key":"25_CR34","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","volume":"330","author":"S Lichtiger","year":"1994","unstructured":"Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy [comments]. N Engl J Med 1994, 330:1841\u20131845.","journal-title":"N Engl J Med"},{"key":"25_CR35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1365-2036.1998.00396.x","volume":"12","author":"WA Stack","year":"1998","unstructured":"Stack WA, Long RG, Hawkey CJ: Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis. Aliment Pharmacol Ther 1998, 12:973\u2013978.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00042737-199805000-00010","volume":"10","author":"GM Hyde","year":"1998","unstructured":"Hyde GM, Thillainayagam AV, Jewell DP: Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol 1998, 10:411\u2013413.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"25_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00054725-199811000-00003","volume":"4","author":"GC Actis","year":"1998","unstructured":"Actis GC, Aimo G, Priolo G, et al.: Efficacy and efficiency of oral microemulsion cyclosporin versus intravenous and soft gelatin capsule cyclosporin in the treatment of severe steroid-refractory ulcerative colitis: an open-label retrospective trial. Inflamm Bowel Dis 1998, 4:276\u2013279.","journal-title":"Inflamm Bowel Dis"},{"key":"25_CR38","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/BF02148846","volume":"38","author":"WR Treem","year":"1995","unstructured":"Treem WR, Cohen J, Davis PM, et al.: Cyclosporine for the treatment of fulminant ulcerative colitis in children. Immediate response, long-term results, and impact on surgery. Dis Colon Rectum 1995, 38:474\u2013479.","journal-title":"Dis Colon Rectum"},{"key":"25_CR39","first-page":"C2886","volume":"116","author":"A Andreoli","year":"1999","unstructured":"Andreoli A, Falasco G, Mangiarotti R, Prantera C: Efficacy of long-term oral 6-mercaptopurine therapy in maintaining remission induced by intravenous cyclosporine in steroid-refractory sever ulcerative colitis. Gastroenterology 1999, 116:C2886.","journal-title":"Gastroenterology"},{"key":"25_CR40","first-page":"G3134","volume":"116","author":"D Geert","year":"1999","unstructured":"Geert D, Lemmens L, Hiele M, et al.: Remission of severe ulcerative colitis with cyclosporine monotherapy is effectively maintained with further immunosuppression. Gastroenterology 1999, 116:G3134.","journal-title":"Gastroenterology"},{"key":"25_CR41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1111\/j.1572-0241.1999.01149.x","volume":"94","author":"RD Cohen","year":"1999","unstructured":"Cohen RD, Stein R, Hanauer SB: Intravenous cyclosporin in ulcerative colitis: a five-year experience. Am J Gastroenterology 1999, 94:1587\u20131592.","journal-title":"Am J Gastroenterology"},{"key":"25_CR42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2036.1999.00511.x","volume":"13","author":"WA Stack","year":"1999","unstructured":"Stack WA, Williams D, Stevenson M, Logan RF: Immunosuppressive therapy for ulcerative colitis: results of a nation-wide survey among consultant physician members of the British Society of Gastroenterology. Aliment Pharmacol Ther 1999, 13:569\u2013575.","journal-title":"Aliment Pharmacol Ther"},{"key":"25_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0889-8553(05)70061-3","volume":"28","author":"JM Becker","year":"1999","unstructured":"Becker JM: Surgical therapy for ulcerative colitis and Crohn\u2019s disease. Gastroenterol Clin North Am 1999, 28:371\u2013390.","journal-title":"Gastroenterol Clin North Am"},{"key":"25_CR44","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0889-8553(21)00368-X","volume":"17","author":"ME Zenilman","year":"1988","unstructured":"Zenilman ME, Becker JM: Emergencies in inflammatory bowel disease. Gastroenterol Clin North Am 1988, 17:387\u2013408.","journal-title":"Gastroenterol Clin North Am"},{"key":"25_CR45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0002-9610(84)90042-4","volume":"147","author":"CS Grant","year":"1984","unstructured":"Grant CS, Dozois RR: Toxic megacolon: ultimate fate of patients after successful medical management. Am J Surg 1984, 147:106\u2013110.","journal-title":"Am J Surg"},{"key":"25_CR46","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02051000","volume":"37","author":"SR Binderow","year":"1994","unstructured":"Binderow SR, Wexner SD: Current surgical therapy for mucosal ulcerative colitis. Dis Colon Rectum 1994, 37:610\u2013624.","journal-title":"Dis Colon Rectum"},{"key":"25_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0889-8553(21)00429-5","volume":"18","author":"LE Smith","year":"1989","unstructured":"Smith LE: Surgical therapy in ulcerative colitis. Gastroenterol Clin North Am 1989, 18:99\u2013110.","journal-title":"Gastroenterol Clin North Am"},{"key":"25_CR48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/bjs.1800590504","volume":"59","author":"JK Ritchie","year":"1972","unstructured":"Ritchie JK: Ulcerative colitis treated by ileostomy and excisional surgery. Fifteen years\u2019 experience at St. Mark\u2019s Hospital. Br J Surg 1972, 59:345\u2013351.","journal-title":"Br J Surg"},{"key":"25_CR49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1744-9987.1997.tb00138.x","volume":"1","author":"K Sawada","year":"1997","unstructured":"Sawada K, Ohnishi K, Kosaka T, et al.: Leukocytapheresis with leukocyte removal filter as new therapy for ulcerative colitis. Ther Apher 1997, 1:207\u2013211.","journal-title":"Ther Apher"},{"key":"25_CR50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1744-9987.1998.tb00084.x","volume":"2","author":"M Sasaki","year":"1998","unstructured":"Sasaki M, Tsujikawa T, Fujiyama Y, Bamba T: Leukocytapheresis therapy for severe ulcerative colitis. Ther Apher 1998, 2:101\u2013104.","journal-title":"Ther Apher"},{"key":"25_CR51","first-page":"G3526","volume":"116","author":"K Sawada","year":"1999","unstructured":"Sawada K, Ohnishi K, Egashira A, et al.: Prospective multicenter randomized study of leukocytapheresis using filter method for ulcerative colitis. Gastroenterology 1999, 116:G3526.","journal-title":"Gastroenterology"},{"key":"25_CR52","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1744-9987.1998.tb00088.x","volume":"2","author":"K Nagase","year":"1998","unstructured":"Nagase K, Sawada K, Ohnishi K, et al.: Complications of leukocytapheresis. Ther Apher 1998, 2:120\u2013124.","journal-title":"Ther Apher"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0025-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-000-0025-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-000-0025-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T14:37:02Z","timestamp":1628951822000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-000-0025-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["25"],"URL":"https:\/\/doi.org\/10.1007\/s11938-000-0025-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]}}}